Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1606 AL 1620

A Comprehensive Analytical Review of Polyphenols: Evaluating Neuroprotection in Alzheimer's Disease

Vicente-Zurdo D, Gómez-Mejía E, Rosales-Conrado N, León-González ME.

Int J Mol Sci. 2024 May 28;25(11):5906. doi: 10.3390/ijms25115906.

Special Issue "Pathophysiology and Treatment of Alzheimer's Disease"

Fessel J.

Int J Mol Sci. 2024 May 30;25(11):6015. doi: 10.3390/ijms25116015.

ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies

Volloch V, Rits-Volloch S.

Int J Mol Sci. 2024 May 30;25(11):6036. doi: 10.3390/ijms25116036.

Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway

Narasimhan S, Holtzman DM, Apostolova LG, Cruchaga C, Masters CL, Hardy J, Villemagne VL, Bell J, Cho M, Hampel H.

Nat Neurosci. 2024 Jul;27(7):1236-1252. doi: 10.1038/s41593-024-01669-5. Epub 2024 Jun 19.

Protection against Alzheimer's Disease with APOE Christchurch Variant - How?

Hardy J.

N Engl J Med. 2024 Jun 20;390(23):2212-2213. doi: 10.1056/NEJMe2403712.

CDK5 as a therapeutic tool for the treatment of Alzheimer's disease: A review

Garemilla S, Kumari R, Kumar R.

Eur J Pharmacol. 2024 Sep 5;978:176760. doi: 10.1016/j.ejphar.2024.176760. Epub 2024 Jun 18.

Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements

Shastri D, Raj V, Lee S.

Ageing Res Rev. 2024 Aug;99:102379. doi: 10.1016/j.arr.2024.102379. Epub 2024 Jun 18.

Modulation of cholesterol metabolism with Phytoremedies in Alzheimer's disease: A comprehensive review

Koppula S, Wankhede NL, Sammeta SS, Shende PV, Pawar RS, Chimthanawala N, Umare MD, Taksande BG, Upaganlawar AB, Umekar MJ, Kopalli SR, Kale MB.

Ageing Res Rev. 2024 Aug;99:102389. doi: 10.1016/j.arr.2024.102389. Epub 2024 Jun 19.

Glyceraldehyde-3-phosphate dehydrogenase is involved in the pathogenesis of Alzheimer's disease

Schmalhausen EV, Medvedeva MV, Muronetz VI.

Arch Biochem Biophys. 2024 Aug;758:110065. doi: 10.1016/j.abb.2024.110065. Epub 2024 Jun 19.

Multifaceted roles of APOE in Alzheimer disease

Jackson RJ, Hyman BT, Serrano-Pozo A.

Nat Rev Neurol. 2024 Aug;20(8):457-474. doi: 10.1038/s41582-024-00988-2. Epub 2024 Jun 21.

Potential therapeutic natural compounds for the treatment of Alzheimer's disease

Huang Q, Wu W, Wen Y, Lu S, Zhao C.

Phytomedicine. 2024 Sep;132:155822. doi: 10.1016/j.phymed.2024.155822. Epub 2024 Jun 12.

Innovation, affordability, access: Alzheimer disease drugs and the Inflation Reduction Act

Li N, Rawal S, Young HN, Villa Zapata L.

Am J Manag Care. 2024 Jun 1;30(6):e169-e171. doi: 10.37765/ajmc.2024.89563.

Brain Iron Dyshomeostasis and Ferroptosis in Alzheimer's Disease Pathophysiology: Two Faces of the Same Coin

Mezzanotte M, Stanga S.

Aging Dis. 2024 Jun 10;16(5):2615-2640. doi: 10.14336/AD.2024.0094.

Mind the Metabolic Gap: Bridging Migraine and Alzheimer's disease through Brain Insulin Resistance

Del Moro L, Pirovano E, Rota E.

Aging Dis. 2024 Jun 16;15(6):2526-2553. doi: 10.14336/AD.2024.0351.

A systematic review of the role of TREM2 in Alzheimer's disease

Yin Y, Yang H, Li R, Wu G, Qin Q, Tang Y.

Chin Med J (Engl). 2024 Jul 20;137(14):1684-1694. doi: 10.1097/CM9.0000000000003000. Epub 2024 Jun 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias